ATE296294T1 - Substituierte benzylthiazolidin-2,4-dion-derivate - Google Patents
Substituierte benzylthiazolidin-2,4-dion-derivateInfo
- Publication number
- ATE296294T1 ATE296294T1 AT00953475T AT00953475T ATE296294T1 AT E296294 T1 ATE296294 T1 AT E296294T1 AT 00953475 T AT00953475 T AT 00953475T AT 00953475 T AT00953475 T AT 00953475T AT E296294 T1 ATE296294 T1 AT E296294T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- unsubstituted
- dione derivatives
- substituted benzylthiazolidine
- substituents
- Prior art date
Links
- JIMXJAFZPUUCAD-UHFFFAOYSA-N 3-benzyl-1,3-thiazolidine-2,4-dione Chemical class O=C1CSC(=O)N1CC1=CC=CC=C1 JIMXJAFZPUUCAD-UHFFFAOYSA-N 0.000 title abstract 3
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 abstract 2
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23552799 | 1999-08-23 | ||
| JP2000242706 | 2000-08-10 | ||
| PCT/JP2000/005519 WO2001014349A1 (en) | 1999-08-23 | 2000-08-18 | Substituted benzylthiazolidine-2,4-dione derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE296294T1 true ATE296294T1 (de) | 2005-06-15 |
Family
ID=26532180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00953475T ATE296294T1 (de) | 1999-08-23 | 2000-08-18 | Substituierte benzylthiazolidin-2,4-dion-derivate |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6730687B1 (de) |
| EP (1) | EP1213287B1 (de) |
| KR (1) | KR100738245B1 (de) |
| CN (1) | CN1155586C (de) |
| AT (1) | ATE296294T1 (de) |
| AU (1) | AU778720B2 (de) |
| CA (1) | CA2382574A1 (de) |
| DE (1) | DE60020381T2 (de) |
| HU (1) | HUP0202520A3 (de) |
| WO (1) | WO2001014349A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7407978B2 (en) * | 1999-04-06 | 2008-08-05 | Theracos, Inc. | Heterocyclic analogs of diphenylethylene compounds |
| TWI262185B (en) * | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
| AU2002222574A1 (en) * | 2000-12-05 | 2002-06-18 | Kyorin Pharmaceutical Co. Ltd. | Substituted carboxylic acid derivatives |
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| AR035533A1 (es) | 2001-01-26 | 2004-06-02 | Schering Corp | Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la |
| EP1911462A3 (de) | 2001-01-26 | 2011-11-30 | Schering Corporation | Zusammensetzungen enthaltend einen Sterolabsorptionshemmer |
| IL156445A0 (en) | 2001-01-26 | 2004-01-04 | Schering Corp | Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| MXPA04002573A (es) | 2001-09-21 | 2004-06-18 | Schering Corp | Tratamiento de xantoma con derivados de azetidinona como inhibidores de la absorcion de esterol. |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| US6908939B2 (en) | 2001-12-21 | 2005-06-21 | Galderma Research & Development S.N.C. | Biaromatic ligand activators of PPARγ receptors |
| FR2833949B1 (fr) * | 2001-12-21 | 2005-08-05 | Galderma Res & Dev | NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS PPARy, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
| FR2836683B1 (fr) * | 2002-03-01 | 2006-06-23 | Galderma Res & Dev | NOUVEAUX LIGANDS ACTIVATEURS DES RECEPTEURS PPARy, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
| WO2004043457A1 (en) | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorptions inhibitors for the treatment of autoimmune disorders |
| US7781464B2 (en) * | 2003-01-17 | 2010-08-24 | Bexel Pharmaceuticals, Inc. | Heterocyclic diphenyl ethers |
| US6794401B2 (en) * | 2003-01-17 | 2004-09-21 | Bexel Pharmaceuticals, Inc. | Amino acid phenoxy ethers |
| US7521465B2 (en) * | 2003-01-17 | 2009-04-21 | Bexel Pharmaceuticals, Inc. | Diphenyl ether derivatives |
| CA2517572C (en) | 2003-03-07 | 2011-12-13 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| JP2006519869A (ja) | 2003-03-07 | 2006-08-31 | シェーリング コーポレイション | 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用 |
| EP1601668B1 (de) | 2003-03-07 | 2008-08-27 | Schering Corporation | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
| US7087576B2 (en) * | 2003-10-07 | 2006-08-08 | Bexel Pharmaceuticals, Inc. | Dipeptide phenyl ethers |
| WO2005058813A2 (en) * | 2003-12-17 | 2005-06-30 | Ranbaxy Laboratories Limited | Thiodiazolidinedione, oxazolidinedione and diazolidinedione derivatives and their use as antidiabetic agents |
| TW200827343A (en) * | 2006-09-11 | 2008-07-01 | Fuji Yakuhin Co Ltd | Novel phenylacetic acid derivative |
| TWI461423B (zh) * | 2008-07-02 | 2014-11-21 | Astrazeneca Ab | 用於治療Pim激酶相關病狀及疾病之噻唑啶二酮化合物 |
| US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
| CN116217511B (zh) * | 2023-03-22 | 2024-04-19 | 沈阳药科大学 | 一种双靶点化合物及其制备方法和在制备sEH抑制剂与PPARs激动剂中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989008650A1 (en) | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
| US5223522A (en) * | 1988-03-08 | 1993-06-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
| JP3144624B2 (ja) * | 1995-06-02 | 2001-03-12 | 杏林製薬株式会社 | Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| JP3929512B2 (ja) | 1995-06-02 | 2007-06-13 | 杏林製薬株式会社 | Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| JP3906935B2 (ja) * | 1995-12-18 | 2007-04-18 | 杏林製薬株式会社 | Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| WO1997032863A1 (en) * | 1996-03-08 | 1997-09-12 | Torii Pharmaceutical Co., Ltd. | Thiazolidine-2,4-dione derivatives |
| NZ314406A (en) | 1996-03-18 | 2000-12-22 | Sankyo Co | Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles |
| JPH09301963A (ja) * | 1996-05-17 | 1997-11-25 | Kyorin Pharmaceut Co Ltd | Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| JP3982645B2 (ja) * | 1996-09-06 | 2007-09-26 | 杏林製薬株式会社 | Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体の製造中間体 |
| GB0127805D0 (en) | 2001-11-20 | 2002-01-09 | Smithkline Beecham Plc | Pharmaceutical composition |
-
2000
- 2000-08-18 HU HU0202520A patent/HUP0202520A3/hu unknown
- 2000-08-18 DE DE60020381T patent/DE60020381T2/de not_active Expired - Fee Related
- 2000-08-18 KR KR1020027001998A patent/KR100738245B1/ko not_active Expired - Fee Related
- 2000-08-18 CA CA002382574A patent/CA2382574A1/en not_active Abandoned
- 2000-08-18 WO PCT/JP2000/005519 patent/WO2001014349A1/ja not_active Ceased
- 2000-08-18 AU AU65945/00A patent/AU778720B2/en not_active Ceased
- 2000-08-18 CN CNB008147086A patent/CN1155586C/zh not_active Expired - Fee Related
- 2000-08-18 US US10/049,645 patent/US6730687B1/en not_active Expired - Fee Related
- 2000-08-18 EP EP00953475A patent/EP1213287B1/de not_active Expired - Lifetime
- 2000-08-18 AT AT00953475T patent/ATE296294T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6730687B1 (en) | 2004-05-04 |
| WO2001014349A1 (en) | 2001-03-01 |
| CN1382129A (zh) | 2002-11-27 |
| KR20020040774A (ko) | 2002-05-30 |
| CN1155586C (zh) | 2004-06-30 |
| EP1213287A1 (de) | 2002-06-12 |
| CA2382574A1 (en) | 2001-03-01 |
| HUP0202520A3 (en) | 2004-11-29 |
| AU6594500A (en) | 2001-03-19 |
| AU778720B2 (en) | 2004-12-16 |
| DE60020381T2 (de) | 2006-01-26 |
| EP1213287B1 (de) | 2005-05-25 |
| EP1213287A4 (de) | 2002-09-18 |
| KR100738245B1 (ko) | 2007-07-12 |
| HUP0202520A2 (hu) | 2002-11-28 |
| DE60020381D1 (de) | 2005-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE296294T1 (de) | Substituierte benzylthiazolidin-2,4-dion-derivate | |
| CY1108586T1 (el) | Υποκαταστημενα παραγωγα φαινυλοπροπιονικου οξεος | |
| ATE296815T1 (de) | Substituierte benzylthiazolidin-2,4-dion derivate | |
| ATE295841T1 (de) | Substituierte benzylthiazolidin-2,4-dion derivate | |
| HUP0000449A2 (hu) | N-szubsztituált dioxo-tiazolidil-benzamid-származékok és eljárás a vegyületek előállítására | |
| ATE235476T1 (de) | Thiazolidindione derivate, ihre herstellung und verwendung | |
| MEP11508A (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
| DE69835004D1 (de) | Neue ethylaminderivate | |
| DK0754682T3 (da) | Aminostilbazolderivat og lægemiddel | |
| ID24846A (id) | Turunan-turunan bifenilamidina | |
| DE69931051D1 (de) | Neue vinylbenzolderivate | |
| JPS5553288A (en) | Heterocyclic derivative*its manufacture and medical composition containing it and having secretion controlling activity | |
| NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
| HUP9901176A2 (hu) | Eljárás 2,2'-bipirrolil-pirrometén-származékok (prodigiozinok) előállítására és intermedierjeik | |
| NO20062936L (no) | Fremgangsmate for fremstilling av N-alkyl-2(hydroksy-4-benzoyl)-3-benzofuraner og dets mellomprodukter derav | |
| FR2629455B1 (fr) | Derives de 2-(3-pyridinyl)3-(phenoxy) propanenitrile | |
| MY130817A (en) | Herbicides | |
| ATE296293T1 (de) | Substituierte benzylthiazolidin-2,4-dion derivate | |
| CA2487450A1 (en) | (2s)-2-ethylphenylpropanoic acid derivatives | |
| MY128711A (en) | Use of thiazole derivatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease | |
| MY140442A (en) | A new process for the preparation of epothilone derivatives | |
| DE69108195D1 (de) | Astaxanthin-Zwischenprodukte. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |